Label: GILTUSS HBP EX EXPECTORANT tablet
- NDC Code(s): 58552-340-07, 58552-340-20
- Packager: Gil Pharmaceutical Corp
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated October 9, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Drug Facts
- Active ingredient Purpose (in each extended-release bi-layer tablet)
- PURPOSE
- Uses
- Warnings
- Ask a doctor before use if you have
- Stop use and ask a doctor if
- PREGNANCY OR BREAST FEEDING
- KEEP OUT OF REACH OF CHILDREN
- Directions
- Other information
- INACTIVE INGREDIENT
- Questions or comments?
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
GILTUSS HBP EX EXPECTORANT
giltuss hbp ex expectorant tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:58552-340 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN 600 mg Inactive Ingredients Ingredient Name Strength CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) (UNII: Z135WT9208) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D) Product Characteristics Color white Score no score Shape OVAL Size 16mm Flavor Imprint Code G Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:58552-340-20 1 in 1 CARTON 10/07/2025 1 20 in 1 BOTTLE; Type 0: Not a Combination Product 2 NDC:58552-340-07 1 in 1 CARTON 10/07/2025 2 7 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M012 10/07/2025 Labeler - Gil Pharmaceutical Corp (176826592) Establishment Name Address ID/FEI Business Operations Neeyaan, LLC 118819217 manufacture(58552-340)

